Last reviewed · How we verify

NCT04546516: PMCF_HYAcorp

Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face

Completed Last updated 17 March 2023
What this trial tests

trial testing HYAcorp Lips and HYAcorp Face in Dermal Filler in 167 participants. Completed in 31 December 2022.

Timeline
8 September 2020
Primary endpoint
22 January 2022
31 December 2022

Quick facts

Lead sponsorBioSCIENCE GmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment167
Start date8 September 2020
Primary completion22 January 2022
Estimated completion31 December 2022
Sites2 locations across Germany

Drugs / interventions tested

Conditions studied

Sponsor

BioSCIENCE GmbH — full company profile →

Who can join

18 and older, any sex, with Dermal Filler. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAcorp Lips and HYAcorp Face for restoration of the facial volume and contour.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other BioSCIENCE GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04546516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing